Quinoline derivatives as phosphodiesterase inhibitors
There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; slv |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | REDGRAVE ALISON JUDITH HOLMAN STUART EVANS BRIAN ELDRED COLIN DAVID LINDVALL MIKA KRISTIAN LUNNISS CHRISTOPHER JAMES HAMBLIN JULIE NICOLE BALDWIN IAN ROBERT ROBINSON JOHN EDWARD GUNTRIP STEPHEN BARRY JONES PAUL REDFERN TRACY JANE GOUGH SHARON LISA WOODROW MICHAEL DEAN ANTHONY WILLIAM BARKER MICHAEL DAVID |
| description | There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI1944305TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI1944305TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI1944305TT13</originalsourceid><addsrcrecordid>eNrjZDANLM3My8_JzEtVSEktyixLLMksSy1WSCxWKMjILwbilMzU4pLUosTiVIXMvIzMpMyS_KJiHgbWtMSc4lReKM3NoOjmGuLsoZtakB-fWlyQmJyal1oSH-xpaGliYmxgGhJiaEyMGgDkey6p</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Quinoline derivatives as phosphodiesterase inhibitors</title><source>esp@cenet</source><creator>REDGRAVE ALISON JUDITH ; HOLMAN STUART ; EVANS BRIAN ; ELDRED COLIN DAVID ; LINDVALL MIKA KRISTIAN ; LUNNISS CHRISTOPHER JAMES ; HAMBLIN JULIE NICOLE ; BALDWIN IAN ROBERT ; ROBINSON JOHN EDWARD ; GUNTRIP STEPHEN BARRY ; JONES PAUL ; REDFERN TRACY JANE ; GOUGH SHARON LISA ; WOODROW MICHAEL ; DEAN ANTHONY WILLIAM ; BARKER MICHAEL DAVID</creator><creatorcontrib>REDGRAVE ALISON JUDITH ; HOLMAN STUART ; EVANS BRIAN ; ELDRED COLIN DAVID ; LINDVALL MIKA KRISTIAN ; LUNNISS CHRISTOPHER JAMES ; HAMBLIN JULIE NICOLE ; BALDWIN IAN ROBERT ; ROBINSON JOHN EDWARD ; GUNTRIP STEPHEN BARRY ; JONES PAUL ; REDFERN TRACY JANE ; GOUGH SHARON LISA ; WOODROW MICHAEL ; DEAN ANTHONY WILLIAM ; BARKER MICHAEL DAVID</creatorcontrib><description>There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120229&DB=EPODOC&CC=SI&NR=1944305T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120229&DB=EPODOC&CC=SI&NR=1944305T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>REDGRAVE ALISON JUDITH</creatorcontrib><creatorcontrib>HOLMAN STUART</creatorcontrib><creatorcontrib>EVANS BRIAN</creatorcontrib><creatorcontrib>ELDRED COLIN DAVID</creatorcontrib><creatorcontrib>LINDVALL MIKA KRISTIAN</creatorcontrib><creatorcontrib>LUNNISS CHRISTOPHER JAMES</creatorcontrib><creatorcontrib>HAMBLIN JULIE NICOLE</creatorcontrib><creatorcontrib>BALDWIN IAN ROBERT</creatorcontrib><creatorcontrib>ROBINSON JOHN EDWARD</creatorcontrib><creatorcontrib>GUNTRIP STEPHEN BARRY</creatorcontrib><creatorcontrib>JONES PAUL</creatorcontrib><creatorcontrib>REDFERN TRACY JANE</creatorcontrib><creatorcontrib>GOUGH SHARON LISA</creatorcontrib><creatorcontrib>WOODROW MICHAEL</creatorcontrib><creatorcontrib>DEAN ANTHONY WILLIAM</creatorcontrib><creatorcontrib>BARKER MICHAEL DAVID</creatorcontrib><title>Quinoline derivatives as phosphodiesterase inhibitors</title><description>There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDANLM3My8_JzEtVSEktyixLLMksSy1WSCxWKMjILwbilMzU4pLUosTiVIXMvIzMpMyS_KJiHgbWtMSc4lReKM3NoOjmGuLsoZtakB-fWlyQmJyal1oSH-xpaGliYmxgGhJiaEyMGgDkey6p</recordid><startdate>20120229</startdate><enddate>20120229</enddate><creator>REDGRAVE ALISON JUDITH</creator><creator>HOLMAN STUART</creator><creator>EVANS BRIAN</creator><creator>ELDRED COLIN DAVID</creator><creator>LINDVALL MIKA KRISTIAN</creator><creator>LUNNISS CHRISTOPHER JAMES</creator><creator>HAMBLIN JULIE NICOLE</creator><creator>BALDWIN IAN ROBERT</creator><creator>ROBINSON JOHN EDWARD</creator><creator>GUNTRIP STEPHEN BARRY</creator><creator>JONES PAUL</creator><creator>REDFERN TRACY JANE</creator><creator>GOUGH SHARON LISA</creator><creator>WOODROW MICHAEL</creator><creator>DEAN ANTHONY WILLIAM</creator><creator>BARKER MICHAEL DAVID</creator><scope>EVB</scope></search><sort><creationdate>20120229</creationdate><title>Quinoline derivatives as phosphodiesterase inhibitors</title><author>REDGRAVE ALISON JUDITH ; HOLMAN STUART ; EVANS BRIAN ; ELDRED COLIN DAVID ; LINDVALL MIKA KRISTIAN ; LUNNISS CHRISTOPHER JAMES ; HAMBLIN JULIE NICOLE ; BALDWIN IAN ROBERT ; ROBINSON JOHN EDWARD ; GUNTRIP STEPHEN BARRY ; JONES PAUL ; REDFERN TRACY JANE ; GOUGH SHARON LISA ; WOODROW MICHAEL ; DEAN ANTHONY WILLIAM ; BARKER MICHAEL DAVID</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI1944305TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>REDGRAVE ALISON JUDITH</creatorcontrib><creatorcontrib>HOLMAN STUART</creatorcontrib><creatorcontrib>EVANS BRIAN</creatorcontrib><creatorcontrib>ELDRED COLIN DAVID</creatorcontrib><creatorcontrib>LINDVALL MIKA KRISTIAN</creatorcontrib><creatorcontrib>LUNNISS CHRISTOPHER JAMES</creatorcontrib><creatorcontrib>HAMBLIN JULIE NICOLE</creatorcontrib><creatorcontrib>BALDWIN IAN ROBERT</creatorcontrib><creatorcontrib>ROBINSON JOHN EDWARD</creatorcontrib><creatorcontrib>GUNTRIP STEPHEN BARRY</creatorcontrib><creatorcontrib>JONES PAUL</creatorcontrib><creatorcontrib>REDFERN TRACY JANE</creatorcontrib><creatorcontrib>GOUGH SHARON LISA</creatorcontrib><creatorcontrib>WOODROW MICHAEL</creatorcontrib><creatorcontrib>DEAN ANTHONY WILLIAM</creatorcontrib><creatorcontrib>BARKER MICHAEL DAVID</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>REDGRAVE ALISON JUDITH</au><au>HOLMAN STUART</au><au>EVANS BRIAN</au><au>ELDRED COLIN DAVID</au><au>LINDVALL MIKA KRISTIAN</au><au>LUNNISS CHRISTOPHER JAMES</au><au>HAMBLIN JULIE NICOLE</au><au>BALDWIN IAN ROBERT</au><au>ROBINSON JOHN EDWARD</au><au>GUNTRIP STEPHEN BARRY</au><au>JONES PAUL</au><au>REDFERN TRACY JANE</au><au>GOUGH SHARON LISA</au><au>WOODROW MICHAEL</au><au>DEAN ANTHONY WILLIAM</au><au>BARKER MICHAEL DAVID</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Quinoline derivatives as phosphodiesterase inhibitors</title><date>2012-02-29</date><risdate>2012</risdate><abstract>There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; slv |
| recordid | cdi_epo_espacenet_SI1944305TT1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Quinoline derivatives as phosphodiesterase inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A42%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=REDGRAVE%20ALISON%20JUDITH&rft.date=2012-02-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI1944305TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |